Application note: Human iPS cells modified with Edit-R™ CRISPR-Cas9 reagents
Modify the genome and modulate expression of genes within human iPS cells with Dharmacon™ Edit-R CRISPR reagents.
Induced pluripotent stem cells are a valuable research tool for their ability to be turned into virtually any cell type. With the advent of CRISPR-Cas9 researchers can modify the genome of the iPS cells and subsequently differentiate them to see the affect that the genomic modification has upon the differentiated cell type. Here we present the ability to modify the genome and modulate expression of genes within a human induced pluripotent stem (iPS) cell line with Dharmacon™ Edit-R CRISPR reagents.
Related content from this organisation
- CRISPR screening to identify new drug targets in regulatory B cells and other immune cells
- Genetic screening to predict the risk of future diseases
- Antimicrobial resistance – a public health emergency on the horizon
- Screening In-Depth Focus 2020
- Application note: 3D cell panel screens for drug discovery and development